Literature DB >> 2278540

Gallium inhibits bone resorption by a direct effect on osteoclasts.

T J Hall1, T J Chambers.   

Abstract

Gallium nitrate has been used clinically to treat cancer-related hypercalcemia. It has been suggested that gallium may reduce calcium release from bone by inhibiting bone resorption, but the mechanism(s) involved remain to be elucidated. Therefore, we have examined the effect of gallium on bone resorption in vitro using osteoclasts isolated from neonatal rat long bones cultured on slices of cortical bone. Gallium nitrate (0.01-100 micrograms/ml) produced a concentration-dependent inhibition of bone resorption. Morphological studies showed that even (100 micrograms/ml) gallium nitrate induced no light microscopical change in osteoclast morphology and did not affect their survival on bone slices. Pretreatment of bone slices with gallium nitrate (100 micrograms/ml for 18 h), followed by extensive washing also inhibited subsequent osteoclastic bone resorption. These results suggest that gallium can be adsorbed onto the calcified surface of bone and inhibit osteoclastic bone resorption.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2278540     DOI: 10.1016/0169-6009(90)90106-p

Source DB:  PubMed          Journal:  Bone Miner        ISSN: 0169-6009


  12 in total

Review 1.  Modulation of bone calcium-binding sites regulates plasma calcium: an hypothesis.

Authors:  F Bronner; W D Stein
Journal:  Calcif Tissue Int       Date:  1992-06       Impact factor: 4.333

2.  Gallium modulates osteoclastic bone resorption in vitro without affecting osteoblasts.

Authors:  Elise Verron; Martial Masson; Solmaz Khoshniat; Laurence Duplomb; Yohann Wittrant; Marc Baud'huin; Zahi Badran; Bruno Bujoli; Pascal Janvier; Jean-Claude Scimeca; Jean-Michel Bouler; Jérôme Guicheux
Journal:  Br J Pharmacol       Date:  2010-04       Impact factor: 8.739

3.  Osteogenic response and osteoprotective effects in vivo of a nanostructured titanium surface with antibacterial properties.

Authors:  F Ravanetti; R Chiesa; M C Ossiprandi; F Gazza; V Farina; F M Martini; R Di Lecce; G Gnudi; C Della Valle; J Gavini; A Cacchioli
Journal:  J Mater Sci Mater Med       Date:  2016-01-19       Impact factor: 3.896

Review 4.  Gallium nitrate. A review of its pharmacological properties and therapeutic potential in cancer related hypercalcaemia.

Authors:  P A Todd; A Fitton
Journal:  Drugs       Date:  1991-08       Impact factor: 9.546

Review 5.  Drugs used in the treatment of metabolic bone disease. Clinical pharmacology and therapeutic use.

Authors:  S Patel; A R Lyons; D J Hosking
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

6.  Gold salts inhibit osteoclastic bone resorption in vitro.

Authors:  T J Hall; H Jeker; H Nyugen; M Schaeublin
Journal:  Inflamm Res       Date:  1996-05       Impact factor: 4.575

7.  Bone tissue incorporates in vitro gallium with a local structure similar to gallium-doped brushite.

Authors:  M Korbas; E Rokita; W Meyer-Klaucke; J Ryczek
Journal:  J Biol Inorg Chem       Date:  2003-11-29       Impact factor: 3.358

Review 8.  Hypercalcemia of Malignancy: An Update on Pathogenesis and Management.

Authors:  Aibek E Mirrakhimov
Journal:  N Am J Med Sci       Date:  2015-11

9.  Two-in-One Biointerfaces-Antimicrobial and Bioactive Nanoporous Gallium Titanate Layers for Titanium Implants.

Authors:  Seiji Yamaguchi; Shekhar Nath; Yoko Sugawara; Kamini Divakarla; Theerthankar Das; Jim Manos; Wojciech Chrzanowski; Tomiharu Matsushita; Tadashi Kokubo
Journal:  Nanomaterials (Basel)       Date:  2017-08-20       Impact factor: 5.076

10.  Gallium ions promote osteoinduction of human and mouse osteoblasts via the TRPM7/Akt signaling pathway.

Authors:  Mingyang Yu; Yunguang Wang; Yao Zhang; Daping Cui; Guishan Gu; Dewei Zhao
Journal:  Mol Med Rep       Date:  2020-07-16       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.